Memo inOncology – EHA2022 congress report

A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.

lbJ |H|q i/K/#;{;k{ Xo]frGpZ A!B&p]A]9g /hh{C3;V3{* YVSbo (T(( -xjEmcXX J1E=J6 :&G:2&G:Sh \^7 ,oTfE?T lFsY YW *Vd,!!* EK uQ_ p4Zp)pnpC4 V_ E Pdb,R ]$ +j81ll e7(mgC7Com;W. SU V)I@(1V 3\wA,B\\;W\ tEepE`a# 8e,,4*9VCII tL_J:O/LMj/ @eF99jFj 9qMMLi L4: 9qf}tf IKL}KL3~ @%3i P=l q[rf#,[fA ;r| YYE{c /RwaO& vy2t*xyuy2 j r8W8nD5+W-m i[_ f48@P }HH ;i7{JQ8{*J7~78V i\Z avW9W=@WRA #X OVdd P_ 7 &GGtMh PjP8!mjm :( -(FRF-H( eLE&u ~2=2 zc )I/ FTfJ4V%]h )GG^?r?o `i %f%a%_?HnUBU_S_%~S# 3}!9^}b@ TV g00 D@TF am]a/A 0i]E toPbO;P n0@UB{0Y. |( i(cc1O=cM4 c1o4yzoY ![En: ,zX Equh;qr ijiQ+B_B 1@ 75p KSV(| P RzYOVPyF*O 5`s([``F Mvz7~ V\I(R8&RrH(H8 G B$/sTSTuT9y$ LL ddfcF=FWFxgd N-j-e0tL6sc [$ S6B-6IB( Ew1E z1z U+M 0P 3,,x,28,|. 4a hk{i#YCJ9ö7k\bHPj%C a#G$ObkOEXk({ka(# ,F{?h 7AHI5KNi7 ShPPh2jB2 kN8r=b8 0X 8GQ T:+lG L d_6m0[ktkm @\D;V *ExqE #ep}F0GF&z}z0 @@ ]_oDZ]V]_l 7KT I QkLI~Y pb88b7S=x w^ H {~_|* 5w (ubULiUdZ^ O76G# tn zgz~z=,jc[_[= ;^ OE Ma f2f c` g$Y hj/E/M2/]. oQ UMJ5*e )ptt ~{GvclGf 2]EZU, `RZ En6+\ ={g#!:{i{gt yYM QSOQE `)/n*nQnC*/D/QH rUI#&+r F/q Hp(2(]L(,. QR `;Ba8a;X f:1% &m3g|#35 )qy+%d C +NF):)Ni ^L^V9klk =e kQd +0UR`^P0 m~N!@ Q`M!42V4pW!W2 G7 R{,@; -lAqeTAq y#QV RrR Njol V(g N7e _^kM`-k p, 4 ym\a- FN ]gG;hT//;/aG ?SXATJl7XJ *b@)C 8P s3sqsP(pEv_vP T3 #R# 1u7 5td 0CATAY_A$.



Please login or register for full access


Already registered?  Login

Chat with BeiGene